Can overuse and free availability of antibiotics without Doctor’s prescription, be contributors to the emergence of drug-resistant diseases in India? What are the available mechanisms for monitoring and control? Critically discuss the various issues involved.
Answer the yes/no part with evidence, set out the monitoring and control mechanisms India actually has, then weigh their gaps, including the access-versus-excess dilemma, and end with a balanced verdict.
Common trap: Weak answers stop at 'yes, overuse causes resistance'. A top answer explains the mechanism (selection pressure), names NDM-1, Schedule H1, the Chennai Declaration and the 2011 national policy, adds non-human drivers (poultry, pharma effluent, poor sanitation), and critically notes that tighter control must not deny antibiotics to the rural poor.
SyllabusScience and Technology — developments and their applications and effects in everyday life; awareness in the fields of biotechnology.
Model answer
12.5 marks · 200-word limitYes. Every unnecessary course of antibiotics exerts selection pressure: susceptible bacteria die and resistant strains multiply and spread. In India, where antibiotics are sold across the counter, prescribed by unqualified practitioners and used heavily in animals, this has made the country a hotspot of resistance, symbolised by the NDM-1 (New Delhi metallo-beta-lactamase) enzyme reported in 2010.
- Over-the-counter and irrational use
- Selection pressure on bacteria
- Resistant strains survive and spread
- First-line drugs fail
- Costlier, last-resort antibiotics used
How overuse and free availability drive resistance
- Self-medication: Chemists sell antibiotics without prescription for colds and diarrhoea, mostly viral illnesses where they are useless, and patients stop courses midway.
- Irrational prescribing: Informal providers, patient pressure, pharma incentives and irrational fixed-dose combinations push broad-spectrum drugs as first choice.
- Non-human drivers: Antibiotics used as growth promoters in poultry and dairy, pharmaceutical effluents near bulk-drug clusters, and poor sanitation spread resistance genes through water and food.
- Hospital transmission: Weak infection control in ICUs turns hospitals into breeding grounds for carbapenem-resistant and multidrug-resistant TB (MDR/XDR-TB) strains.
Available monitoring and control mechanisms
- Legal: The Drugs and Cosmetics Act, 1940 lists prescription drugs under Schedule H; Schedule H1 (from March 2014) covers newer antibiotics and anti-TB drugs, requires a red-bordered warning label and a separate sales register at the chemist.
- Policy: The National Policy for Containment of Antimicrobial Resistance (2011) called for surveillance, rational-use guidelines and hospital infection-control committees; the Chennai Declaration (2012) gave a medical-community roadmap.
- Surveillance: ICMR's antimicrobial resistance surveillance network, NCDC labs and the RNTCP's drug-resistance surveys track resistance patterns, though coverage is limited.
Issues: why control remains weak
- Enforcement gap: State drug controllers have too few inspectors for lakhs of retail chemists, so prescription rules are widely ignored.
- Access versus excess: In rural India many people die for lack of antibiotics; a blunt ban on over-the-counter sale could hurt them where doctors are absent.
- Data and sectors: There is little data on antibiotic use in animals and the environment, and health, agriculture and pollution regulators work in silos.
- Innovation gap: Few new antibiotics are being developed globally, so protecting existing drugs is the only near-term defence.
Resistance is a slow-moving pandemic, and India needs a One Health approach: enforced prescription rules, antibiotic stewardship in hospitals, curbs on growth-promoter use, treatment of pharma effluents and public awareness, while widening access to qualified care. (Later, India adopted a National Action Plan on AMR in 2017 and the 'Red Line' awareness campaign in 2016.)
Read more — sources
- OfficialMinistry of Health & Family Welfare, National Policy for Containment of Antimicrobial Resistance, India (2011)
- OfficialDrugs and Cosmetics Rules, 1945 — Schedule H1 (inserted by the 2013 amendment, in force from 1 March 2014)
- ReportChennai Declaration on tackling antimicrobial resistance (2012), Indian Journal of Medical Microbiology
- ReportWHO, Antimicrobial Resistance: Global Report on Surveillance (2014)
More from GS Paper 3 2014
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.